BENDER LEWIS H 4
4 · INTENSITY THERAPEUTICS, INC. · Filed Mar 30, 2026
Research Summary
AI-generated summary of this filing
Intensity Therapeutics CEO Lewis H. Bender Receives Stock Award
What Happened
Lewis H. Bender, President & CEO and a director of Intensity Therapeutics (INTS), was granted 37,749 shares on 2026-03-26 as a fully vested stock award (reported as an acquisition) at an attributable price of $6.11 per share, for a total value of $230,646. The award was granted under the company's 2021 Stock Incentive Plan in partial satisfaction of his 2025 bonus, given at his request.
Key Details
- Transaction date and price: 2026-03-26; 37,749 shares at $6.11/share; total value $230,646. (Transaction code: A = Award/Grant)
- Shares owned after transaction: Not specified in this Form 4.
- Footnotes:
- F1 — Award was fully vested and granted in partial satisfaction of the 2025 bonus in lieu of cash, at the reporting person's request.
- F2 — All reported amounts have been adjusted for a 1-for-25 reverse stock split effective 2026-02-18; outstanding equity awards were proportionately adjusted.
- Filing timeliness: Form 4 filed 2026-03-30 reporting the 2026-03-26 transaction; filed within the required two business days.
Context
This was a compensation-related stock award (not an open-market purchase or sale). Fully vested awards increase the insider’s ownership immediately and are commonly used to satisfy bonuses or other pay obligations; they do not necessarily indicate a separate, discretionary market purchase or change in sentiment.
Insider Transaction Report
- Award
Common Stock, $0.0001 Par Value
[F1][F2]2026-03-26$6.11/sh+37,749$230,646→ 118,549 total
Footnotes (2)
- [F1]Granted to the Reporting Person as a fully vested stock award under the Issuer's 2021 Stock Incentive Plan in partial satisfaction of the 2025 bonus payment to the Reporting Person in lieu of cash, at the Reporting Person's request.
- [F2]On February 18, 2026, the Issuer effectuated a 1-for-25 reverse split of the Issuer's common stock resulting in a reduction in the number of shares held by the Reporting Person. In addition, proportionate adjustments were made to the Issuer's outstanding equity awards. Accordingly, all amounts of securities reported in this Form 4 have been adjusted to reflect the 1-for-25 reverse split.